November 2025 in “Mendeley Data” Botulinum toxin may improve hair transplant success by enhancing graft survival and hair density.
November 2025 in “Mendeley Data” Botulinum toxin may improve hair transplant success by enhancing graft survival and hair density.
November 2025 in “Mendeley Data” This study investigates the impact of botulinum toxin (BoNT) on hair transplantation outcomes through a randomized split-scalp controlled trial. BoNT, known for its cosmetic and therapeutic uses, has shown potential in treating hair disorders like androgenetic alopecia (AGA). The study hypothesizes that BoNT can enhance hair transplantation outcomes by improving the scalp microenvironment, increasing local oxygenation, and reducing ischemia-induced graft failure. The trial aims to determine if preoperative BoNT administration can improve graft survival and hair density in patients undergoing hair transplantation.
February 2023 in “Frontiers in Bioengineering and Biotechnology” Optical imaging and light therapy show promise for diagnosing and treating liver injury caused by surgery.
1 citations
,
December 2010 in “Elsevier eBooks” Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.